Clinical Study
Fibroblast Growth Factor 23 Predicts Left Ventricular Mass and Induces Cell Adhesion Molecule Formation
Table 1
Comparison of the baseline characteristics between the patients with CKD and control patients with essential hypertension (EH).
| | CKD () | EH () | P value |
| Age (years) | | | 0.072 | Male sex | 75% () | 74% () | 0.94 | DM nephropathy | 62% () | NA | | eGFR (mL/min/1.73 m2) | | | <0.001 | LVMI | 81.2 (70.2–97.6) | 86 (71.6–99.6) | 0.419 | Systolic BP (mmHg) | | | 0.48 | Diastolic BP | | | <0.001 | Phosphate (mmol/L) | | | <0.001 | Vitamin D (ng/mL) | 13 (5–20) | 20.5 (14–26.8) | 0.004 | FGF-23 (RU/mL) | 237.9 (109.6–393.3) | 12.5 (1.5–35.9) | <0.001 | PTH (pg/mL) | 14.5 (6.7–21.6) | 5.7 (4.8–7.3) | <0.001 | Calcium (mmol/L) | | | 0.096 | Ur PRC (mg/mmol) | 82.5 (19.75–218) | NA | |
|
|